BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gu Q, Xia H, Song YQ, Duan J, Chen Y, Zhang Y, Chen HP, Zhang L. SLC6A14 promotes ulcerative colitis progression by facilitating NLRP3 inflammasome-mediated pyroptosis. World J Gastroenterol 2024; 30(3): 252-267 [PMID: 38314135 DOI: 10.3748/wjg.v30.i3.252]
URL: https://www.wjgnet.com/1007-9327/full/v30/i3/252.htm
Number Citing Articles
1
Bin Feng, Yanqiu Zhang, Longwei Qiao, Qingqin Tang, Zheng Zhang, Sheng Zhang, Jun Qiu, Xianping Zhou, Chao Huang, Yuting Liang. Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessmentFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1426875
2
Yanbei Ren, Ting Wang, Jiuheng Yin. The role of soluble epoxide hydrolase in the intestineCell Biology International 2024; 48(11): 1612 doi: 10.1002/cbin.12232
3
Kun Zhang, Jianlan Xie, Jianmin Zhao, Mei Jia. Predictive Value of PHRI for Recurrence within One Year after UC Treatment: A Retrospective StudyBritish Journal of Hospital Medicine 2024; : 1 doi: 10.12968/hmed.2024.0425
4
Jinzhen Peng, Shuai Tang, Lifang Huang, Ye Fang. Protective role of TRPM7 knockdown in ulcerative colitis via blocking NLRP3 inflammasome-mediated pyroptosisProstaglandins & Other Lipid Mediators 2024; 175: 106904 doi: 10.1016/j.prostaglandins.2024.106904
5
Yifan Liu, Renjie Pan, Yuzhen Ouyang, Wangning Gu, Tengfei Xiao, Hongmin Yang, Ling Tang, Hui Wang, Bo Xiang, Pan Chen. Pyroptosis in health and disease: mechanisms, regulation and clinical perspectiveSignal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01958-2